652 EPAC-mTORC1 signaling regulates proliferation of primary melanoma cells and loss of dependence on EPAC signaling correlates with melanoma progression
نویسندگان
چکیده
Exchange Proteins directly Activated by cAMP (EPACs) belong to a family of RAP guanine nucleotide exchange factors (RAPGEF). EPAC1/2 (RAPGEF3/4) activate RAP1 and the alternative signaling pathway. We previously showed that differential growth response primary metastatic melanoma cells is mediated EPAC. However, mechanisms responsible for this EPAC are not understood. In study, we show pharmacological inhibition or siRNA-mediated knockdown selectively inhibits survival downregulation cell cycle proteins inhibiting progression independent ERK1/2 phosphorylation. results in upregulation AKT phosphorylation but mTORC1 activity its downstream effectors. also regulates both glycolysis oxidative phosphorylation, production mitochondrial reactive oxygen species, preferentially cells. Employing series genetically matched lymph node (LNM) cells, distant organ (MM) LNM MM become progressively less responsive refractory suggesting loss dependency on correlates with progression. Analysis TCGA dataset lower RAPGEF3, RAPGEF4 mRNA expression tumor predictor better disease-free patients diagnosed facilitates useful prognostic marker. These data highlight as potential target prevention
منابع مشابه
Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression
Elizabeth R. Snedecor1,3,9, Clifford Sung1,4,9, Alejandra Moncayo1,5, Brooke E. Rothstein1,6, Daniel C. Mockler1, Marcia G. Tonnesen2,8, Evan C. Jones2, Mayumi Fujita7, Richard A. Clark2,5, Kenneth R. Shroyer1, and Jiang Chen1,2 1Department of Pathology, Stony Brook University, Stony Brook, NY 11794 2Department of Dermatology, Stony Brook University, Stony Brook, NY 11794 3Program in Genetics, ...
متن کاملEPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.
Cyclic AMP (cAMP) is an important second messenger that regulates a wide range of physiologic processes. In mammalian cutaneous melanocytes, cAMP-mediated signaling pathways activated by G-protein-coupled receptors (GPCR), like melanocortin 1 receptor (MC1R), play critical roles in melanocyte homeostasis including cell survival, proliferation, and pigment synthesis. Impaired cAMP signaling is a...
متن کاملSpinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling.
Spinal serotonin type 7 (5-HT7) receptors elicit complex effects on motor activity. Whereas 5-HT7 receptor activation gives rise to long-lasting phrenic motor facilitation (pMF), it also constrains 5-HT2 receptor-induced pMF via "cross-talk inhibition." We hypothesized that divergent cAMP-dependent signaling pathways give rise to these distinct 5-HT7 receptor actions. Specifically, we hypothesi...
متن کاملEpac-Rap signaling reduces oxidative stress in the tubular epithelium.
Activation of Rap1 by exchange protein activated by cAMP (Epac) promotes cell adhesion and actin cytoskeletal polarization. Pharmacologic activation of Epac-Rap signaling by the Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP during ischemia-reperfusion (IR) injury reduces renal failure and application of 8-pCPT-2'-O-Me-cAMP promotes renal cell survival during exposure to the nephrotoxicant cisp...
متن کاملLoss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling
Triapine, an anticancer thiosemicarbazone, is currently under clinical investigation. Whereas promising results were obtained in hematological diseases, trials in solid tumors widely failed. To understand mechanisms causing triapine insensitivity, we have analysed genomic alterations in a triapine-resistant SW480 subline (SW480/tria). Only one distinct genomic loss was observed specifically in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 2022
ISSN: ['1523-1747', '0022-202X']
DOI: https://doi.org/10.1016/j.jid.2022.05.663